Skip to main content
Log in

Reducing reflex first-line prescriptions in a surgical pathology laboratory: toward sustainable practice with positive economic and clinical effects

  • ORIGINAL ARTICLE
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

In surgical pathology departments, reflex first-line techniques (RFLTs) are aimed at reducing workloads and addressing recent shortages of medical personnel. However, the impacts thereof on economic and diagnostic factors have been poorly addressed. Also, in the era of global warming, environmental considerations are crucial. This study assessed the economic and diagnostic efficacies of routine pathological RFLT and the quality of care and sustainability. Ten RFLTs of the Bordeaux University Hospital pathology department (six special stains, one cytology technique, and three immunohistochemical tests) were studied. First, a retrospective economic analysis evaluated the average cost of these RFLTs per slide and per year. Second, diagnostic relevance was prospectively surveyed. Third, the effects of changes made were analyzed over 2 years. The ten RFLTs were associated with average annual costs of €46,708. Diagnostic relevance analysis indicated that most stains were unnecessary; only 17% were requested as second-line techniques. Elimination of 7/10 tests afforded annual cost savings of €22,522 and reduced the workload by 5568 tests/year, without compromising the workflow or diagnostic quality. Seven of ten RFLTs could be eliminated without compromising diagnostic quality or the workflow. This afforded not only financial benefits but also positive social and environmental impacts. We offer valuable insights into appropriate practices in surgical pathology laboratories. Collaboration between the medical and technical teams was crucial; other healthcare sectors would also benefit from our approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

The data that support the findings of this study are available from the corresponding author, R.V., upon reasonable request.

References

  1. Torous VF, Pitman MB, Ly A (2020) Evaluation of the clinical utility of reflex GMS and AFB stains on BAL specimens from lung transplant patients. J Am Soc Cytopathol 9(3):166–172

    Article  PubMed  Google Scholar 

  2. Scherer LC, Sperhacke RD, Maria R-NA, Kritski AL (2011) Usefulness of the polymerase chain reaction dot-blot assay, used with Ziehl-Neelsen staining, for the rapid and conveni ent diagnosis of pulmonary tuberculosis in human immuno deficiency virus-seropositive and – seronegative individuals. Infect Dis Rep [cited 2021 Feb 21] 3(1):e3–e3. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892596/

  3. Theegarten D, Tötsch M, Worm K, Darwiche K, Anhenn O, Wohlschläger J (2013) Diagnosis of pulmonary tuberculosis using Ziehl-Neelsen stain and polymerase chain reaction. Pathol 34(4):305–309

    Article  CAS  Google Scholar 

  4. Murphy JK, O’Donohue L (2004) The diagnostic value and cost effectiveness of routine fungal stains in a dermatopathology service of a district general hospital. J Clin Pathol 57(2):139–140

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Pittman ME, Khararjian A, Wood LD, Montgomery EA, Voltaggio L (2016) Prospective identification of Helicobacter pylori in routine gastric biopsies without reflex ancillary stains is cost-efficient for our health care system. Hum Pathol 58:90–96

    Article  PubMed  Google Scholar 

  6. Panarelli NC, Ross DS, Bernheim OE, Landzberg ZB, Schuetz AN, Jenkins SG et al (2015) Utility of ancillary stains for Helicobacter pylori in near-normal gastric biopsies. Hum Pathol 46(3):397–403

    Article  PubMed  Google Scholar 

  7. Gordon IO, Sherman JD, Leapman M, Overcash M, Thiel CL (2021) Life cycle greenhouse gas emissions of gastrointestinal biopsies in a surgical pathology laboratory. Am J Clin Pathol 156(4):540–549

    Article  CAS  PubMed  Google Scholar 

  8. Leapman MS, Thiel CL, Gordon IO, Nolte AC, Perecman A, Loeb S et al (2023) Environmental impact of prostate magnetic resonance imaging and transrectal ultrasound guided prostate biopsy. Eur Urol 83(5):463–471

    Article  PubMed  Google Scholar 

  9. Pichler PP, Jaccard IS, Weisz U, Weisz H (2019) International comparison of health care carbon footprints. Environ Res Lett 14(6):064004

    Article  Google Scholar 

  10. The Shift Project (2023) Décarbonner la santé pour soigner durablement [Internet]. theshiftproject.org. The Shift Project; [cited 2023 Jun 14] p 1–176. Available from: https://theshiftproject.org/wp-content/uploads/2023/04/180423-TSP-PTEF-Rapport-final-Sante_v2.pdf

  11. McAlister S, Barratt AL, Bell KJ, McGain F (2020) The carbon footprint of pathology testing. Med J Aust 212(8):377–382

    Article  PubMed  Google Scholar 

  12. Barratt A, McGain F (2021) Overdiagnosis is increasing the carbon footprint of healthcare. BMJ 4(375):n2407

    Article  Google Scholar 

  13. Haute Autorité de Santé. Choix méthodologiques pour l’évaluation économique à la HAS [Internet]. has-sante.fr. Haute Autorité de Santé; [cited 2023 Aug 7] p 1–83. Available from: https://has-sante.fr/upload/docs/application/pdf/2011-11/guide_methodo_vf.pdf

  14. Brusseau ML, Pepper IL, Gerba CP (2019) Environmental and pollution science. Academic Press, an imprint of Elsevier, London, United Kingdom

    Google Scholar 

  15. van Walraven C, Naylor CD (1998) Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. JAMA 280(6):550–558

    Article  PubMed  Google Scholar 

  16. Dickerson JA, Cole B, Conta JH, Wellner M, Wallace SE, Jack RM et al (2014) Improving the value of costly genetic reference laboratory testing with active utilization management. Arch Pathol Lab Med 138(1):110–113

    Article  PubMed  Google Scholar 

  17. Watts RD, Li IW, Geelhoed EA, Sanfilippo FM, St. John A (2017) Economic evaluations of pathology tests, 2010–2015: a scoping review. Value Health 20(8):1210–5

    Article  PubMed  Google Scholar 

  18. Wilson ML (2015) Decreasing inappropriate laboratory test utilization: controlling costs and improving quality of care. Am J Clin Pathol 143(5):614–616

    Article  PubMed  Google Scholar 

  19. Procop GW, Keating C, Stagno P, Kottke-Marchant K, Partin M, Tuttle R et al (2015) Reducing duplicate testing: a comparison of two clinical decision support tools. Am J Clin Pathol 143(5):623–626

    Article  PubMed  Google Scholar 

  20. IPCC (2023) Climate change 2023: Synthesis report. In: Core Writing Team, Lee H, Romero J (eds) Contribution of working groups I, II and III to the Sixth assessment report of the intergovernmental panel on climate change. IPCC, Geneva

    Google Scholar 

  21. Romanello M, McGushin A, Napoli CD, Drummond P, Hughes N, Jamart L et al (2021) The 2021 report of the Lancet Countdown on health and climate change: code red for a healthy future. Lancet 398(10311):1619–1662

    Article  PubMed  Google Scholar 

  22. Eckelman MJ, Sherman JD, MacNeill AJ (2018) Life cycle environmental emissions and health damages from the Canadian healthcare system: an economic-environmental-epidemiological analysis. PLOS Med 15(7):e1002623

    Article  PubMed  PubMed Central  Google Scholar 

  23. Malik A, Lenzen M, McAlister S, McGain F (2018) The carbon footprint of Australian health care. Lancet Planet Health 2(1):e27–e35

    Article  PubMed  Google Scholar 

  24. United Nations Framework Convention on Climate Change (2023) Paris climate change conference - report of the conference of the parties on its twenty-first session, held in Paris from 30 November to 13 December 2015 [Internet]. [cited 2023 Aug 11]. Available from: https://unfccc.int/sites/default/files/english_paris_agreement.pdf

  25. Bernard N (2021) L’hôpital en transition. Afnor, Paris

    Google Scholar 

Download references

Acknowledgements

We would like to thank the entire surgical pathology department, the supervisory and administrative staff, and the management of Bordeaux University Hospital, in particular, Clément Castera (accounting) who facilitated the economic study and Marielle Lahiton (logistics) for providing the raw data regarding reagents.

Author information

Authors and Affiliations

Authors

Contributions

Remi Vergara wrote this work as part of his publicly defended medical thesis, under the guidance of Marion Marty, who designed the study plan. Anne Rullier largely contributed to the ecological and sustainable development aspects of this work. Genevieve Belleannée and Rudy Chouvel promoted the thesis at the national level in France. Béatrice Vergier and Marie-Laure Martin-Négrier served as members of the thesis jury, with Brigitte Le Bail who provided valuable input and helped it evolve.

Corresponding author

Correspondence to Rémi Vergara.

Ethics declarations

Ethics approval

The data used in this article is derived from routine laboratory activities and is entirely anonymous. It reflects the general functioning of the laboratory and does not involve any specific patient information. As such, it does not require individual patient data recording or ethical approval. Our study strictly adheres to ethical standards and data privacy regulations.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Short abstract

This study evaluated the economic, diagnostic, and environmental costs incurred by a surgical pathology department of a tertiary hospital. We focused on ten reflex first-line systematic analyses (RFLT), thus special stains and immunostainings, and revealed that the elimination of seven of the ten tests afforded substantial cost savings without compromising diagnostic quality or the workflow, illustrating the feasibility and benefits afforded by appropriate practices in a surgical pathology laboratory.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vergara, R., Chouvel, R., Vergier, B. et al. Reducing reflex first-line prescriptions in a surgical pathology laboratory: toward sustainable practice with positive economic and clinical effects. Virchows Arch (2024). https://doi.org/10.1007/s00428-024-03817-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00428-024-03817-5

Keywords

Navigation